Join
Live feed
·
INSIDERFilingvia Quantisnow
Verrica Pharmaceuticals Inc. logo

Amendment: CHIEF LEGAL OFFICER Hayes Christopher G. was granted 150,000 shares, increasing direct ownership by 183% to 231,925 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRCA· Verrica Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRCA (Verrica Pharmaceuticals Inc.) and more on Quantisnow.